Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gene therapy in interventional coronary interventions].

Arnd B Buchwald1

  • 1Abteilung Kardiologie und Pneumologie, Herzzentrum Göttingen, Universitätsklinik, Germany. buchwald@med.uni-goettingen.de

Herz
|October 16, 2002
PubMed
Summary
This summary is machine-generated.

Restenosis after angioplasty affects many patients, with stents and brachytherapy showing promise. Gene therapy offers targeted approaches, but clinical trials are pending, raising questions about its future efficacy compared to current methods.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression of the leptin receptor in different types of vascular lesions.

Histochemistry and cell biology·2007
Same author

Transfection of the DNA for the receptor KDR/flk-1 attenuates neointimal proliferation and luminal narrowing in a coronary stent angioplasty model.

The Journal of surgical research·2006
Same author

Shear stress insensitivity of endothelial nitric oxide synthase expression as a genetic risk factor for coronary heart disease.

Circulation research·2004
Same author

Decoy oligodeoxynucleotide against activator protein-1 reduces neointimal proliferation after coronary angioplasty in hypercholesterolemic minipigs.

Journal of the American College of Cardiology·2002
Same author

Closure of an iatrogenic aortocoronary arteriovenous fistula: transcatheter balloon embolization following failed coil embolization and salvage of coils that migrated into the coronary venous system.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2002
Same journal

[Advancing cardiovascular prevention : Evidence-based design of healthy and sustainable food environments].

Herz·2026
Same journal

[Effects of air pollution on cardiovascular health].

Herz·2026
Same journal

[Heart and climate].

Herz·2026
Same journal

Multidimensional psychosocial screening in routine cardiac care: preliminary findings from a cross-sectional survey.

Herz·2026
Same journal

[Noise and the heart].

Herz·2026
Same journal

[The cardiovascular exposome: areas of action for prevention and practical cardiology].

Herz·2026
See all related articles

Area of Science:

  • Cardiovascular research
  • Interventional cardiology
  • Molecular biology

Background:

  • Restenosis affects 30-50% of patients post-percutaneous coronary intervention (PCI).
  • Pharmacologic strategies have limited success in reducing restenosis rates.
  • Stenting and brachytherapy significantly improve long-term outcomes after coronary angioplasty.

Purpose of the Study:

  • To explore the potential of gene therapy in reducing neointimal hyperplasia and restenosis.
  • To compare gene therapy strategies with existing interventions like stenting and brachytherapy.

Main Methods:

  • Investigating gene expression modulation (inhibition/overexpression) post-angioplasty.
  • Evaluating various gene therapy strategies targeting different molecular pathways (e.g., ligand-receptor binding, cell cycle, apoptosis).
  • Analyzing results from animal experimental models of angioplasty.

Main Results:

  • Studies show significant reduction in neointimal hyperplasia in animal models by modulating specific gene expressions.
  • Multiple gene therapy strategies targeting different pathways have demonstrated success in experimental settings.
  • Clinical trial results for gene therapy to reduce restenosis are not yet published.

Conclusions:

  • Gene therapy presents a promising avenue for specifically targeting restenosis mechanisms.
  • The redundancy in signaling pathways leading to restenosis suggests multiple targets for intervention.
  • The development of clinically viable gene therapy for restenosis faces challenges, especially compared to established methods like stenting and emerging eluting stents.